Showing results (41-50 of 90) with videos related to
Sort By:
Pageof 9
The Journal of Clinical Investigation|August 18, 2004
Prevalent expression of the immunostimulatory MHC class I chain-related molecule is counteracted by shedding in prostate cancerJennifer D Wu, Lily M Higgins, Alexander Steinle, et al.Cancer Research|October 20, 2004
RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivoManuel A Friese, Jörg Wischhusen, Wolfgang Wick, et al.International Journal of Cancer|February 10, 2010
The BCR/ABL-inhibitors imatinib, nilotinib and dasatinib differentially affect NK cell reactivityJulia Salih, Julia Hilpert, Theresa Placke, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 8, 2018
Cellular Mechanisms Controlling Surfacing of AICL Glycoproteins, Cognate Ligands of the Activating NK Receptor NKp80Sebastian Neuss, Yvonne Bartel, Christina Born, et al.International Journal of Cancer|May 25, 2011
Impaired tumor rejection by memory CD8 T cells in mice with NKG2D dysfunctionMaya Caroline André, Dagmar Sigurdardottir, Sabrina Kuttruff, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 23, 2017
NKG2D-Dependent Antitumor Effects of Chemotherapy and Radiotherapy against GlioblastomaTobias Weiss, Hannah Schneider, Manuela Silginer, et al.Cancer Research|November 22, 2011
Tumor suppressive microRNAs miR-34a/c control cancer cell expression of ULBP2, a stress-induced ligand of the natural killer cell receptor NKG2DAnja Heinemann, Fang Zhao, Sonali Pechlivanis, et al.The Journal of Biological Chemistry|October 19, 2016
The Stalk Domain of NKp30 Contributes to Ligand Binding and Signaling of a Preassembled NKp30-CD3ζ ComplexStefanie Memmer, Sandra Weil, Steffen Beyer, et al.Mabs|May 10, 2023
Engaging natural killer cells for cancer therapy via NKG2D, CD16A and other receptorsKerry A Whalen, Kavya Rakhra, Naveen K Mehta, et al.Oncotarget|October 4, 2014
MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escapePaula Codo, Michael Weller, Gunter Meister, et al.Pageof 9